Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fluoxetine response: endpoint vs pattern analysis.

R R Fieve, P J Goodnick, E Peselow

    International Clinical Psychopharmacology
    |October 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Corrigendum to "French validation of the Acceptance of Modern Myths about Sexual Aggression scale (AMMSA) and experience of close relationships with students and perpetrators of domestic violence" [Encephale 2021;47:554-563] https://doi.org/10.1016/j.encep.2020.11.010].

    L'Encephale·2022
    Same author

    [French validation of the Acceptance of Modern Myths about Sexual Aggression scale (AMMSA) and experience of close relationships with students and perpetrators of domestic violence].

    L'Encephale·2021
    Same author

    Hypothermic machine perfusion in liver transplantation.

    International journal of surgery (London, England)·2020
    Same author

    Reply to: "The UK DCD Risk Score: Still no consensus on futility in DCD liver transplantation".

    Journal of hepatology·2019
    Same author

    Can hypothermic oxygenated perfusion (HOPE) rescue futile DCD liver grafts?

    HPB : the official journal of the International Hepato Pancreato Biliary Association·2019
    Same author

    The impact of ileal pouch-anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitis.

    Alimentary pharmacology & therapeutics·2018
    Same journal

    Critical reassessment of manic and psychotic episodes related to levetiracetam: a systematic review of published case reports.

    International clinical psychopharmacology·2026
    Same journal

    Expanding the horizon of brexpiprazole augmentation in treatment-resistant disorders: from obsessive-compulsive disorder to adolescent bipolar disorder.

    International clinical psychopharmacology·2026
    Same journal

    Acceptability-adjusted speed in psychotic agitation: interpreting pro re nata antipsychotic data in real-world care (commentary on Hatta et al.).

    International clinical psychopharmacology·2026
    Same journal

    Antipsychotics in clinical practice: agitation, polypharmacy, and treatment resistance.

    International clinical psychopharmacology·2026
    Same journal

    Methylphenidate treatment in adults with comorbid attention-deficit/hyperactivity disorder and borderline personality disorder: a prospective longitudinal study.

    International clinical psychopharmacology·2026
    Same journal

    Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD).

    International clinical psychopharmacology·2026
    See all related articles

    This study on fluoxetine for major depressive disorder found that while endpoint scores didn't differ between groups, analyzing persistent response patterns successfully distinguished fluoxetine's effectiveness from placebo.

    Area of Science:

    • Psychiatry
    • Clinical Pharmacology
    • Neuroscience

    Background:

    • Major depressive disorder (MDD) is a prevalent and debilitating mental health condition.
    • Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) commonly prescribed for depression.
    • Evaluating treatment efficacy requires robust methodologies to distinguish drug effects from placebo responses.

    Purpose of the Study:

    • To assess the efficacy of fluoxetine in treating unipolar major depressive disorder over a 6-week period.
    • To investigate the relationship between changes in depression rating scales and overall clinical improvement.
    • To determine if pattern analysis of treatment response can differentiate active drug effects from placebo.

    Main Methods:

    • A 6-week, double-blind, placebo-controlled trial involving 49 patients with unipolar MDD.

    Related Experiment Videos

  • Utilized the Hamilton Depression Rating Scale (HDRS) and Clinical Global Improvement (CGI) scores for assessment.
  • Employed both endpoint analysis and pattern analysis of persistent response for efficacy evaluation.

    • Main Results:

    • A correlation was observed between HDRS score changes (absolute and percentage decrease) and final CGI ratings.
    • No significant differences were found between fluoxetine and placebo when analyzing endpoint HDRS and CGI scores, likely due to placebo responders.
    • Pattern analysis of persistent response successfully differentiated the active drug group from the placebo group (p < 0.05).

    Conclusions:

    • While endpoint analyses may be confounded by placebo effects in depression trials, pattern analysis of persistent response offers a more sensitive method.
    • Fluoxetine demonstrated efficacy in treating major depressive disorder, as evidenced by pattern analysis distinguishing its effects from placebo.
    • This study highlights the importance of employing advanced analytical techniques to accurately assess antidepressant efficacy.